Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

Predictive factors of left ventricular mass changes after treatment of primary aldosteronism.

Catena C, Colussi GL, Marzano L, Sechi LA.

Horm Metab Res. 2012 Mar;44(3):188-93. doi: 10.1055/s-0032-1301902. Epub 2012 Feb 20.

PMID:
22351477
2.

Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism.

Catena C, Colussi G, Lapenna R, Nadalini E, Chiuch A, Gianfagna P, Sechi LA.

Hypertension. 2007 Nov;50(5):911-8. Epub 2007 Sep 24.

3.

[Left ventricular myocardial structure and function in patients with primary aldosteronism].

Arabidze GG, Chikhladze NM, Sergakova LM, Iarovaia EB.

Ter Arkh. 1999;71(9):13-9. Russian.

PMID:
10553618
4.

Regression of left ventricular hypertrophy in patients with primary aldosteronism/low-renin hypertension on low-dose spironolactone.

Ori Y, Chagnac A, Korzets A, Zingerman B, Herman-Edelstein M, Bergman M, Gafter U, Salman H.

Nephrol Dial Transplant. 2013 Jul;28(7):1787-93. doi: 10.1093/ndt/gfs587. Epub 2013 Feb 1.

5.

Cardiovascular outcomes in patients with primary aldosteronism after treatment.

Catena C, Colussi G, Nadalini E, Chiuch A, Baroselli S, Lapenna R, Sechi LA.

Arch Intern Med. 2008 Jan 14;168(1):80-5. doi: 10.1001/archinternmed.2007.33.

PMID:
18195199
6.

Reversal of myocardial fibrosis in patients with unilateral hyperaldosteronism receiving adrenalectomy.

Lin YH, Lee HH, Liu KL, Lee JK, Shih SR, Chueh SC, Lin WC, Lin LC, Lin LY, Chung SD, Wu VC, Kuo CC, Ho YL, Chen MF, Wu KD; TAIPAI Study Group.

Surgery. 2011 Sep;150(3):526-33. doi: 10.1016/j.surg.2011.02.006. Epub 2011 Apr 22.

PMID:
21514614
7.

Comparison of changes in cardiac structure after treatment in secondary hypertension.

Yoshitomi Y, Nishikimi T, Abe H, Yoshiwara F, Suzuki T, Ashizawa A, Nagata S, Kuramochi M, Matsuoka H, Omae T.

Hypertension. 1996 Mar;27(3 Pt 1):319-23.

8.

Rapid reversal of left ventricular hypertrophy and intracardiac volume overload in patients with resistant hypertension and hyperaldosteronism: a prospective clinical study.

Gaddam K, Corros C, Pimenta E, Ahmed M, Denney T, Aban I, Inusah S, Gupta H, Lloyd SG, Oparil S, Husain A, Dell'Italia LJ, Calhoun DA.

Hypertension. 2010 May;55(5):1137-42. doi: 10.1161/HYPERTENSIONAHA.109.141531. Epub 2010 Mar 29.

9.

Adrenalectomy reverses myocardial fibrosis in patients with primary aldosteronism.

Lin YH, Wu XM, Lee HH, Lee JK, Liu YC, Chang HW, Lin CY, Wu VC, Chueh SC, Lin LC, Lo MT, Ho YL, Wu KD; TAIPAI Study Group.

J Hypertens. 2012 Aug;30(8):1606-13. doi: 10.1097/HJH.0b013e3283550f93.

PMID:
22688266
10.

Changes in left ventricular anatomy and function in hypertension and primary aldosteronism.

Rossi GP, Sacchetto A, Visentin P, Canali C, Graniero GR, Palatini P, Pessina AC.

Hypertension. 1996 May;27(5):1039-45.

11.

Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study.

Giacchetti G, Ronconi V, Turchi F, Agostinelli L, Mantero F, Rilli S, Boscaro M.

J Hypertens. 2007 Jan;25(1):177-86.

PMID:
17143190
12.

Long-term control of arterial hypertension and regression of left ventricular hypertrophy with treatment of primary aldosteronism.

Rossi GP, Cesari M, Cuspidi C, Maiolino G, Cicala MV, Bisogni V, Mantero F, Pessina AC.

Hypertension. 2013 Jul;62(1):62-9. doi: 10.1161/HYPERTENSIONAHA.113.01316. Epub 2013 May 6. Erratum in: Hypertension. 2014 Dec;64(6):e7.

13.

Factors influencing left ventricular mass regression in patients with primary aldosteronism post adrenalectomy.

Lin YH, Huang KH, Lee JK, Wang SM, Yen RF, Wu VC, Chung SD, Liu KL, Chueh SC, Lin LY, Ho YL, Chen MF, Wu KD; TAIPAI study group.

J Renin Angiotensin Aldosterone Syst. 2011 Mar;12(1):48-53. doi: 10.1177/1470320310376424. Epub 2010 Aug 18.

PMID:
20719880
14.

Role of aldosterone in left ventricular hypertrophy in hypertension.

Matsumura K, Fujii K, Oniki H, Oka M, Iida M.

Am J Hypertens. 2006 Jan;19(1):13-8.

PMID:
16461184
15.

Left ventricular hypertrophy precedes other target-organ damage in primary aldosteronism.

Shigematsu Y, Hamada M, Okayama H, Hara Y, Hayashi Y, Kodama K, Kohara K, Hiwada K.

Hypertension. 1997 Mar;29(3):723-7.

17.

Renal cysts and hypokalemia in primary aldosteronism: results of long-term follow-up after treatment.

Novello M, Catena C, Nadalini E, Colussi GL, Baroselli S, Chiuch A, Lapenna R, Bazzocchi M, Sechi LA.

J Hypertens. 2007 Jul;25(7):1443-50.

PMID:
17563567
18.

The association of serum potassium level with left ventricular mass in patients with primary aldosteronism.

Lin YH, Wang SM, Wu VC, Lee JK, Kuo CC, Yen RF, Liu KL, Huang KH, Chueh SC, Wang WJ, Lin LY, Chien KL, Ho YL, Chen MF, Wu KD; TAIPAI study group.

Eur J Clin Invest. 2011 Jul;41(7):743-50. doi: 10.1111/j.1365-2362.2010.02462.x. Epub 2011 Jan 21.

PMID:
21250985
19.

Inappropriate left ventricular mass in patients with primary aldosteronism.

Muiesan ML, Salvetti M, Paini A, Agabiti-Rosei C, Monteduro C, Galbassini G, Belotti E, Aggiusti C, Rizzoni D, Castellano M, Agabiti-Rosei E.

Hypertension. 2008 Sep;52(3):529-34. doi: 10.1161/HYPERTENSIONAHA.108.114140. Epub 2008 Jul 21.

20.

Left ventricular hypertrophy is more prominent in patients with primary aldosteronism than in patients with other types of secondary hypertension.

Tanabe A, Naruse M, Naruse K, Hase M, Yoshimoto T, Tanaka M, Seki T, Demura R, Demura H.

Hypertens Res. 1997 Jun;20(2):85-90.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk